{"sha1": "e131eabdc560498bfcae04e0a89d167d24a412bc", "filename_exif": "4171.txt", "extension_exif": "TXT", "last_modified_exif": "2021:09:23 16:30:10+10:00", "create_date_exif": null, "access_date_exif": "2023:09:23 14:24:05+10:00", "modify_date_exif": "2021:09:23 16:30:10+10:00", "mime_type_exif": "text/plain", "file_size_exif": 14195, "title_exif": "", "path_components_exif": ["data", "medical_papers"], "publication_date_exif": "", "author_exif": "", "organizational_unit_exif": "", "content": "\n\n\n\n\n\n\n\n\n\n\u00b7\u4e34\u5e8a\u7814\u7a76\u00b7\u5fc3\u810f\u79fb\u690d\u672f\u540e\u5de6\u53f3\u5fc3\u5ba4\u529f\u80fd\u53d8\u5316\u7684\u4e34\u5e8a\u4ef7\u503c\u6f58\u7fe0\u73cd\u6768\u58f0\u663e\u8212\u5148\u7ea2\u738b\u6625\u751f\u9648\u660a\u6731\u4ed5\u6770\u3010\u6458\u8981\u3011\u76ee\u7684\u63a2\u8ba8\u5fc3\u810f\u79fb\u690d\u672f\u540e\u5de6\u53f3\u5fc3\u5ba4\u6536\u7f29\u53ca\u8212\u5f20\u529f\u80fd\u7684\u53d8\u5316\u7684\u4e34\u5e8a\u4ef7\u503c\u3002\u65b9\u6cd52000\u5e748\u6708\u81f32007\u5e746\u6708\u5728\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u4e2d\u5c71\u533b\u9662\u884c\u5fc3\u810f\u79fb\u690d\u540e\u968f\u8bbf\u7684\u60a3\u800520\u4f8b,\u884c\u5e38\u89c4\u8d85\u58f0\u68c0\u67e5;\u5e94\u7528\u8109\u51b2\u591a\u666e\u52d2\u8bb0\u5f55\u4e8c\u5c16\u74e3\u3001\u4e3b\u52a8\u8109\u74e3\u3001\u4e09\u5c16\u74e3\u3001\u80ba\u52a8\u8109\u74e3\u8840\u6d41\u56fe;\u7ec4\u7ec7\u591a\u666e\u52d2\u8bb0\u5f55\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u56fe\u8c31;\u5b9e\u65f6\u4e09\u7ef4\u8d85\u58f0\u5fc3\u52a8\u56fe\u6d4b\u91cf\u5de6\u5fc3\u5ba4\u5c04\u8840\u5206\u6570\u3002\u5e76\u4e0e\u6b63\u5e38\u5bf9\u7167\u7ec4\u8fdb\u884c\u6bd4\u8f83\u3002\u7ed3\u679c\u5fc3\u810f\u79fb\u690d\u7ec4\u5de6\u623f\u5185\u5f84\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u660e\u663e\u589e\u5927(P<0.01),\u53f3\u5ba4\u7684Tei\u6307\u6570\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u9ad8(P<0.05)\u3002\u4e09\u5c16\u74e3\u53e3\u8840\u6d41\u56fe\u5fc3\u810f\u79fb\u690d\u7ec4A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u9ad8(P<0.01),E/A\u6bd4\u503c\u5fc3\u810f\u79fb\u690d\u7ec4\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e(P<0.05);\u4e09\u5c16\u74e3\u74e3\u73af\u53f3\u5ba4\u4fa7\u58c1\u7684\u6536\u7f29\u901f\u5ea6\u3001E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u5747\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e(P<0.01,P<0.05,P<0.05),E/A\u6bd4\u503c\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u9ad8(P<0.05);\u53f3\u5ba4\u4fa7\u58c1\u7684\u6536\u7f29\u901f\u5ea6\u3001E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u5747\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e(P\u5747<0.05),E/A\u6bd4\u503c\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u9ad8(P<0.05)\u3002\u7ed3\u8bba\u5fc3\u810f\u79fb\u690d\u7ec4\u5176\u53f3\u5ba4\u6536\u7f29\u529f\u80fd\u51cf\u9000,\u800c\u5de6\u5ba4\u6536\u7f29\u529f\u80fd\u53ca\u5de6\u53f3\u5ba4\u8212\u5f20\u529f\u80fd\u672a\u89c1\u660e\u663e\u5f02\u5e38\u3002\u3010\u5173\u952e\u8bcd\u3011\u5fc3\u810f\u79fb\u690d;\u5fc3\u5ba4\u529f\u80fd;\u8d85\u58f0\u68c0\u67e5,\u591a\u666e\u52d2;Tei\u6307\u6570EchocardiographicparametersforassessingleftandrightventricularfunctionafterhearttransplantationPANCui-zhen,YANGSheng-xian,SHUXian-hong,WANGChun-sheng,CHENHao,ZHUShi-jie.DepartmentofEchocardiography,ZhongshanHospital,FudanUniversity,ShanghaiInstituteofCardiovascularDiseases,Shanghai200032,ChinaCorrespondingauthor:PANCui-zhen,Email:Pan.cuizhen@zs-hospital.sh.cn\u3010Abstract\u3011ObjectiveToinvestigatethevalueofleftandrightfunctionvarietyafterhearttransplantation.MethodsTwentyhearttransplantswerestudiedon\u57fa\u91d1\u9879\u76ee:\u4e0a\u6d77\u5e02\u79d1\u59d4\u91cd\u5927\u9879\u76ee(024119001);\u4e0a\u6d77\u5e02\u91cd\u70b9\u5b66\u79d1\u5efa\u8bbe\u9879\u76ee(B116)\u4f5c\u8005\u5355\u4f4d:200032\u4e0a\u6d77,\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u4e2d\u5c71\u533b\u9662\u4e0a\u6d77\u5e02\u5fc3\u8840\u7ba1\u75c5\u7814\u7a76\u6240\u8d85\u58f0\u5fc3\u52a8\u56fe\u5ba4(\u6f58\u7fe0\u73cd\u3001\u6768\u58f0\u663e\u3001\u8212\u5148\u7ea2),\u5fc3\u5916\u79d1(\u738b\u6625\u751f\u3001\u9648\u660a\u3001\u6731\u4ed5\u6770)\u901a\u8baf\u4f5c\u8005:\u6f58\u7fe0\u73cd,Email:Pan.cuizhen@zs-hospital.sh.cn\u00b71218\u00b7\u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7(\u7535\u5b50\u7248)2008\u5e7411\u6708\u7b2c2\u5377\u7b2c11\u671fChinJClinicians(ElectronicVersion),November15,2008,Vol.2,No.11\ufffdtwo-dimensionalechocardiography,pulsedwaveDoppler,tissueDopplerandthree-dimensionalechocardiography.ResultsLeftatrialdiameterinhearttransplantswasenlargerthannormalsubjects(P<0.01),rightventricularTeiindex,velocityofpeakAintricuspidwerehigherthanthoseofthenormalsubjects(P<0.05,P<0.01,respectively),theratioofE/Aintricuspidwaslowerthanthatofthenormalsubjects(P<0.05),systolicvelocityintricuspidannulusandrightventricularwall,velocityofpeakEandpeakAwerereducedsignificantlycomparedwiththenormalsubjects(P<0.01,P<0.05,P<0.05,respectively),whiletheratioofE/Awasincreasedsignificantlycomparedwiththenormalsubjects(P<0.05).ConclusionsRightventricularsystolicfunctionisreducedinhearttransplant.\u3010Keywords\u3011Hearttransplantation;Ventricularfunction;Ultrasonography,Doppler;Teiindex\u5fc3\u810f\u79fb\u690d\u662f\u7ec8\u672b\u671f\u5fc3\u810f\u75c5\u60a3\u8005\u7684\u60df\u4e00\u6cbb\u7597\u624b\u6bb5,\u76ee\u524d\u56fd\u5185\u591a\u91c7\u7528\u539f\u4f4d\u5fc3\u810f\u79fb\u690d,\u539f\u4f4d\u5fc3\u810f\u79fb\u690d\u540e\u51fa\u73b0\u6025\u6027\u548c\u6162\u6027\u6392\u65a5\u53cd\u5e94\u65f6,\u5de6\u53f3\u5fc3\u5ba4\u7684\u6536\u7f29\u53ca\u8212\u5f20\u529f\u80fd\u5c06\u4f1a\u53d1\u751f\u53d8\u5316\u3002\u672c\u7814\u7a76\u5e94\u7528\u4e8c\u7ef4\u8d85\u58f0\u5fc3\u52a8\u56fe\u3001\u8109\u51b2\u591a\u666e\u52d2\u3001\u7ec4\u7ec7\u591a\u666e\u52d2\u8bc4\u4ef7\u5fc3\u810f\u79fb\u690d\u672f\u540e\u5de6\u53f3\u5fc3\u5ba4\u7684\u6536\u7f29\u53ca\u8212\u5f20\u529f\u80fd\u3002\u8d44\u6599\u4e0e\u65b9\u6cd5\u4e00\u3001\u4e00\u822c\u8d44\u6599\u672c\u7ec4\u5fc3\u810f\u79fb\u690d\u60a3\u8005\u517120\u4f8b,\u5747\u4e3a2000\u5e748\u6708\u81f32007\u5e746\u6708\u5728\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u4e2d\u5c71\u533b\u9662\u884c\u5fc3\u810f\u79fb\u690d\u540e\u968f\u8bbf\u7684\u60a3\u8005,\u968f\u8bbf\u65f6\u95f42~84\u4e2a\u6708,\u5e73\u5747(17.70\u00b113.91)\u4e2a\u6708,\u753715\u4f8b,\u59735\u4f8b,\u5e74\u9f8411~61\u5c81,\u5e73\u5747(41.4\u00b114.85)\u5c81\u3002\u672f\u524d\u4e34\u5e8a\u8bca\u65ad,14\u4f8b\u4e3a\u6269\u5f20\u6027\u5fc3\u808c\u75c5\u7ec8\u672b\u671f;2\u4f8b\u4e3a\u7f3a\u8840\u6027\u5fc3\u808c\u75c5;1\u4f8b\u4e3a\u975e\u6897\u963b\u6027\u80a5\u539a\u578b\u5fc3\u808c\u75c5\u4f34\u4e2d\u91cd\u5ea6\u80ba\u52a8\u8109\u9ad8\u538b;1\u4f8b\u4e3a\u4e3b\u52a8\u8109\u74e3\u66ff\u6362\u672f\u540e,\u5de6\u5ba4\u660e\u663e\u589e\u5927\u4f34\u5de6\u5ba4\u58c1\u6574\u4f53\u6536\u7f29\u6d3b\u52a8\u666e\u904d\u51cf\u5f31(LVEF\u4e3a23%);1\u4f8b\u4e8c\u5c16\u74e3\u7f6e\u6362\u672f\u540e,\u5de6\u5ba4\u660e\u663e\u589e\u5927\u4f34\u5de6\u5ba4\u58c1\u6574\u4f53\u6536\u7f29\u6d3b\u52a8\u666e\u904d\u51cf\u5f31(LVEF\u4e3a25%);1\u4f8b\u5fc3\u810f\u80bf\u7624\u672f\u540e\u590d\u53d1\u300220\u4f8b\u672f\u540e\u5747\u672a\u51fa\u73b0\u6025\u6027\u6216\u6162\u6027\u6392\u65a5\u53cd\u5e94(20\u4f8b\u5747\u7ecf\u5fc3\u808c\u6d3b\u68c0\u8bc1\u5b9e)\u300230\u4f8b\u4e3a\u6b63\u5e38\u5bf9\u7167\u7ec4,\u753715\u4f8b,\u597315\u4f8b,\u5e74\u9f8424~76\u5c81,\u5e73\u5747(41.03\u00b113.3)\u5c81\u3002\u4e8c\u3001\u4eea\u5668\u548c\u65b9\u6cd51.\u4eea\u5668:PHILIPSIE33\u5fc3\u60a6\u8d85\u58f0\u663e\u50cf\u4eea,S5\u63a2\u5934,\u9891\u73871~5MHz,X3-1\u63a2\u5934,\u9891\u7387\u4e3a1~3MHz\u30022.\u65b9\u6cd5:(1)\u53d7\u68c0\u8005\u53d6\u5de6\u4fa7\u5367\u4f4d\u6216\u5e73\u5367\u4f4d,\u8fde\u63a5\u5fc3\u7535\u56fe;(2)\u5e94\u7528S5\u63a2\u5934\u505a\u00b71219\u00b7\u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7(\u7535\u5b50\u7248)2008\u5e7411\u6708\u7b2c2\u5377\u7b2c11\u671fChinJClinicians(ElectronicVersion),November15,2008,Vol.2,No.11\ufffd\u5e38\u89c4\u8d85\u58f0\u68c0\u67e5,\u6d4b\u91cf\u4e3b\u52a8\u8109\u6839\u90e8\u5185\u5f84\u3001\u5de6\u623f\u53ca\u5de6\u5ba4\u5927\u5c0f\u3001\u5ba4\u95f4\u9694\u53ca\u5de6\u5ba4\u540e\u58c1\u539a\u5ea6;\u5e94\u7528\u8109\u51b2\u591a\u666e\u52d2\u8bb0\u5f55\u4e8c\u5c16\u74e3\u53e3\u8840\u6d41\u56fe\u3001\u4e3b\u52a8\u8109\u53e3\u8840\u6d41\u56fe\u3001\u4e09\u5c16\u74e3\u53e3\u8840\u6d41\u56fe\u3001\u80ba\u52a8\u8109\u53e3\u8840\u6d41\u56fe;\u7136\u540e\u5728\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u5207\u6362\u4e3a\u7ec4\u7ec7\u591a\u666e\u52d2\u8bb0\u5f55\u4e8c\u5c16\u74e3\u73af\u4fa7\u58c1\u53ca\u5ba4\u95f4\u9694\u3001\u4e09\u5c16\u74e3\u74e3\u73af\u53f3\u5ba4\u4fa7\u58c1\u901f\u5ea6\u56fe;(3)\u5e94\u7528X3-1\u63a2\u5934\u4e8e\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u5f97\u5230\u7406\u60f3\u7684\u5de6\u5ba4\u56fe\u50cf\u540e,\u542f\u52a8fullvolume\u663e\u50cf\u65b9\u5f0f\u91c7\u96c6\u91d1\u5b57\u5854\u5f62\u4e09\u7ef4\u6570\u636e\u5e93(\u75314\u4e2a\u6247\u89d2\u5bbd60\u00b0\u3001\u53d6\u6837\u539a\u5ea615\u00b0\u7684\u74dc\u74e3\u56fe\u53e0\u52a0\u800c\u6210),\u518d\u5e94\u7528\u529f\u80fd\u952e,\u4efb\u610f\u65cb\u8f6c\u548c\u5207\u5272\u56fe\u50cf,\u4f7f\u9700\u89c2\u5bdf\u7684\u5fc3\u810f\u7ed3\u6784\u6ee1\u610f\u663e\u793a\u3002\u7136\u540e\u5c06\u91c7\u96c6\u7684\u8d44\u6599\u50a8\u5b58\u5230\u5149\u76d8,\u8fdb\u884c\u8131\u673a\u5206\u6790\u3002\u4e09\u3001\u7edf\u8ba1\u5b66\u5904\u7406\u91c7\u7528SPSS11.5\u7edf\u8ba1\u8f6f\u4ef6\u5305\u548cMicrosoftOffice97Excel\u8f6f\u4ef6\u8fdb\u884c\u7edf\u8ba1\u5206\u6790\u3002\u8ba1\u91cf\u6570\u636e\u8d44\u6599\u4ee5\u5747\u6570\u00b1\u6807\u51c6\u5dee(x\u00b1s)\u8868\u793a,\u4ee5t\u68c0\u9a8c\u6bd4\u8f83\u7ec4\u95f4\u5dee\u522b\u3002P<0.05\u4e3a\u5dee\u5f02\u6709\u7edf\u8ba1\u5b66\u610f\u4e49\u3002\u7ed3\u679c1.\u5fc3\u810f\u79fb\u690d\u7ec4\u548c\u6b63\u5e38\u5bf9\u7167\u7ec4R-R\u95f4\u671f\u3001\u5e38\u89c4\u8d85\u58f0\u6d4b\u91cf\u6570\u636e\u3001LVEF\u3001\u5de6\u53f3\u5ba4Tei\u6307\u6570\u7684\u6bd4\u8f83\u7ed3\u679c(\u88681):\u5fc3\u810f\u79fb\u690d\u7ec4\u5176R-R\u95f4\u671f\u8f83\u6b63\u5e38\u7ec4\u77ed(P<0.01),\u5de6\u623f\u5185\u5f84\u8f83\u6b63\u5e38\u7ec4\u5927(P<0.01),\u53f3\u5ba4\u7684Tei\u6307\u6570\u8f83\u6b63\u5e38\u7ec4\u9ad8(P<0.05)\u3002\u88681\u4e24\u7ec4\u60a3\u8005R-R\u95f4\u671f\u3001\u5e38\u89c4\u8d85\u58f0\u6d4b\u91cf\u6570\u636e\u3001LVEF\u3001\u5de6\u53f3\u5ba4Tei\u6307\u6570\u7684\u6bd4\u8f83(x\u00b1s)\u7ec4\u522bR-R\u95f4\u671f(ms)AORD(mm)LAD(mm)LVDd(mm)LVDs(mm)\u6b63\u5e38\u7ec4836.80\u00b198.8032.00\u00b13.1033.10\u00b12.6247.50\u00b13.9828.30\u00b13.02\u79fb\u690d\u7ec4640.50\u00b158.40b35.60\u00b11.0046.10\u00b14.11b49.60\u00b13.2130.00\u00b12.60P\u503c0.0010.180.000010.210.31\u7ec4\u522bIVST(mm)PWT(mm)LVEF(3D)(%)LV-TeiRV-Tei\u6b63\u5e38\u7ec410.60\u00b10.6710.40\u00b10.7266.17\u00b15.790.33\u00b10.100.27\u00b10.10\u79fb\u690d\u7ec410.89\u00b11.2111.00\u00b10.7956.82\u00b19.310.38\u00b10.110.39\u00b10.07aP\u503c0.350.270.100.320.01\u6ce8:\u4e0e\u6b63\u5e38\u7ec4\u6bd4\u8f83,aP<0.05,bP<0.012.\u5fc3\u810f\u79fb\u690d\u7ec4\u548c\u6b63\u5e38\u5bf9\u7167\u7ec4\u4e8c\u5c16\u74e3\u53e3\u3001\u4e09\u5c16\u74e3\u53e3\u8840\u6d41\u56fe\u7684\u6bd4\u8f83\u7ed3\u679c(\u88682):(1)\u4e8c\u5c16\u74e3\u53e3\u8840\u6d41\u56fe:E\u5cf0\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u5fc3\u810f\u79fb\u690d\u7ec4\u8f83\u6b63\u5e38\u7ec4\u4f4e(P<0.05),\u800cE/A\u6bd4\u503c\u4e24\u7ec4\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49(P>0.05)\u3002(2)\u4e09\u5c16\u74e3\u53e3\u8840\u6d41\u56fe:E\u5cf0\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u5fc3\u810f\u79fb\u690d\u7ec4\u8f83\u6b63\u5e38\u7ec4\u9ad8,\u4f46E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u4e24\u7ec4\u6bd4\u8f83\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49(P>0.05),A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u4e24\u7ec4\u6bd4\u8f83\u5dee\u5f02\u6709\u663e\u8457\u7edf\u8ba1\u5b66\u610f\u4e49(P<0.01),E/A\u6bd4\u503c\u5fc3\u810f\u79fb\u690d\u7ec4\u8f83\u6b63\u5e38\u7ec4\u4f4e(P<0.05)\u30023.\u5fc3\u810f\u79fb\u690d\u7ec4\u548c\u6b63\u5e38\u5bf9\u7167\u7ec4\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u5de6\u5ba4\u4e8c\u5c16\u74e3\u6c34\u5e73\u4fa7\u58c1\u901f\u5ea6\u56fe\u3001\u5ba4\u95f4\u9694\u901f\u5ea6\u56fe\u4ee5\u53ca\u4e09\u5c16\u74e3\u74e3\u73af\u53f3\u5ba4\u4fa7\u58c1\u901f\u5ea6\u56fe\u7684\u6bd4\u8f83\u7ed3\u679c(\u88683,\u56fe1):\u5fc3\u810f\u79fb\u00b71220\u00b7\u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7(\u7535\u5b50\u7248)2008\u5e7411\u6708\u7b2c2\u5377\u7b2c11\u671fChinJClinicians(ElectronicVersion),November15,2008,Vol.2,No.11\ufffd\u690d\u7ec4\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u5de6\u5ba4\u4e8c\u5c16\u74e3\u6c34\u5e73\u4fa7\u58c1\u7684\u6536\u7f29\u901f\u5ea6\u3001E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001E/A\u6bd4\u503c\u5747\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e,\u4f46\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49(P\u5747>0.05);\u5ba4\u95f4\u9694\u7684\u6536\u7f29\u901f\u5ea6\u3001E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001E/A\u6bd4\u503c\u5747\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e,\u4f46\u4ec5E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u4e24\u7ec4\u6bd4\u8f83\u5dee\u5f02\u6709\u663e\u8457\u7edf\u8ba1\u5b66\u610f\u4e49(P<0.01);\u4e09\u5c16\u74e3\u74e3\u73af\u53f3\u5ba4\u4fa7\u58c1\u7684\u6536\u7f29\u901f\u5ea6\u3001E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u5747\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e(P<0.01,P<0.05,P<0.05),E/A\u6bd4\u503c\u8f83\u6b63\u5e38\u7ec4\u9ad8(P<0.05)\u3002\u88682\u4e24\u7ec4\u60a3\u8005\u4e8c\u5c16\u74e3\u53e3\u3001\u4e09\u5c16\u74e3\u53e3\u8840\u6d41\u56fe\u7684\u6bd4\u8f83(x\u00b1s)\u7ec4\u522bMV-E(cm/s)MV-A(cm/s)MV-E/ATV-E(cm/s)TV-A(cm/s)TV-E/A\u6b63\u5e38\u7ec482.21\u00b113.2554.42\u00b19.991.62\u00b10.4757.80\u00b18.9833.57\u00b14.591.86\u00b10.50\u79fb\u690d\u7ec471.32\u00b111.25a40.90\u00b17.60a1.60\u00b10.2560.20\u00b110.8951.47\u00b110.37b1.17\u00b10.13aP\u503c0.040.010.960.640.0020.03\u6ce8:\u4e0e\u6b63\u5e38\u7ec4\u6bd4\u8f83,aP<0.05,bP<0.01\u88683\u4e24\u7ec4\u60a3\u8005\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u5de6\u5ba4\u4e8c\u5c16\u74e3\u6c34\u5e73\u4fa7\u58c1\u901f\u5ea6\u56fe\u3001\u5ba4\u95f4\u9694\u901f\u5ea6\u56fe\u4ee5\u53ca\u4e09\u5c16\u74e3\u74e3\u73af\u53f3\u5ba4\u4fa7\u58c1\u901f\u5ea6\u56fe\u7684\u6bd4\u8f83(x\u00b1s)\u7ec4\u522bLVLWmv-S(cm/s)LVLWmv-E(cm/s)LVLWmv-A(cm/s)LVLWmv-E/ALVSWmv-S(cm/s)LVSWmv-E(cm/s)\u6b63\u5e38\u7ec411.48\u00b12.8413.99\u00b14.178.14\u00b12.581.92\u00b10.808.33\u00b12.0110.89\u00b12.27\u79fb\u690d\u7ec49.99\u00b11.5712.38\u00b11.247.14\u00b11.761.84\u00b10.496.81\u00b11.506.81\u00b11.60bP\u503c0.290.260.230.800.090.003\u7ec4\u522bLVSWmv-A(cm/s)LVSWmv-E/ARVWtv-S(cm/s)RVWtv-E(cm/s)RVWtv-A(cm/s)RVWtv-E/A\u6b63\u5e38\u7ec47.54\u00b12.641.66\u00b10.6311.36\u00b12.3711.60\u00b12.4910.13\u00b12.191.17\u00b10.22\u79fb\u690d\u7ec45.92\u00b11.721.46\u00b10.358.40\u00b11.83b8.99\u00b12.66a7.28\u00b11.76a1.54\u00b10.51aP\u503c0.100.070.0020.010.040.03\u6ce8:\u4e0e\u6b63\u5e38\u7ec4\u6bd4\u8f83,aP<0.05,bP<0.014.\u5fc3\u810f\u79fb\u690d\u7ec4\u548c\u6b63\u5e38\u5bf9\u7167\u7ec4\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u5de6\u5ba4\u4fa7\u58c1\u901f\u5ea6\u56fe\u3001\u5ba4\u95f4\u9694\u901f\u5ea6\u00b71221\u00b7\u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7(\u7535\u5b50\u7248)2008\u5e7411\u6708\u7b2c2\u5377\u7b2c11\u671fChinJClinicians(ElectronicVersion),November15,2008,Vol.2,No.11\ufffd\u56fe\u4ee5\u53ca\u53f3\u5ba4\u4fa7\u58c1\u901f\u5ea6\u56fe\u7684\u6bd4\u8f83\u7ed3\u679c(\u88684,\u56fe2):\u5fc3\u810f\u79fb\u690d\u7ec4\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u5de6\u5ba4\u4fa7\u58c1\u3001\u5ba4\u95f4\u9694\u7684\u6536\u7f29\u901f\u5ea6\u3001E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001E/A\u6bd4\u503c\u5747\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e,\u4f46\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49(P\u5747>0.05);\u800c\u53f3\u5ba4\u4fa7\u58c1\u7684\u6536\u7f29\u901f\u5ea6\u3001E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u5747\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e(P\u5747<0.05),E/A\u6bd4\u503c\u8f83\u6b63\u5e38\u7ec4\u9ad8(P<0.05)\u3002\u88684\u4e24\u7ec4\u60a3\u8005\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u5de6\u5ba4\u4fa7\u58c1\u901f\u5ea6\u56fe\u3001\u5ba4\u95f4\u9694\u901f\u5ea6\u56fe\u4ee5\u53ca\u53f3\u5ba4\u4fa7\u58c1\u901f\u5ea6\u56fe\u7684\u6bd4\u8f83(x\u00b1s)\u7ec4\u522bLVLW-S(cm/s)LVLW-E(cm/s)LVLW-A(cm/s)LVLW-E/ALVSW-S(cm/s)LVSW-E(cm/s)\u6b63\u5e38\u7ec45.23\u00b11.044.98\u00b11.894.95\u00b11.661.06\u00b10.805.12\u00b11.115.12\u00b11.02\u79fb\u690d\u7ec44.28\u00b11.314.28\u00b11.164.86\u00b11.760.89\u00b10.493.94\u00b11.044.15\u00b11.02P\u503c0.310.360.390.800.090.10\u7ec4\u522bLVSW-A(cm/s)LVSW-E/ARVW-S(cm/s)RVW-E(cm/s)RVW-A(cm/s)RVW-E/A\u6b63\u5e38\u7ec44.89\u00b11.801.05\u00b10.636.25\u00b11.327.12\u00b11.566.89\u00b11.761.03\u00b10.22\u79fb\u690d\u7ec44.61\u00b11.750.90\u00b10.352.15\u00b10.79a2.95\u00b10.86a2.15\u00b11.14a1.37\u00b10.51aP\u503c0.100.60.010.010.030.04\u6ce8:\u4e0e\u6b63\u5e38\u7ec4\u6bd4\u8f83,aP<0.05\u8ba8\u8bbaTei\u6307\u6570\u662f\u8bc4\u4ef7\u5fc3\u810f\u529f\u80fd\u7684\u4e00\u4e2a\u65b0\u7684\u8d85\u58f0\u6307\u6807,\u4e3a\u5fc3\u5ba4\u7b49\u5bb9\u6536\u7f29\u671f(ICT)\u4e0e\u7b49\u5bb9\u8212\u5f20\u671f(IRT)\u4e4b\u548c\u4e0e\u5fc3\u5ba4\u5c04\u8840\u65f6\u95f4(ET)\u7684\u6bd4\u503c,\u53cd\u6620\u7684\u662f\u5fc3\u5ba4\u6536\u7f29\u548c\u8212\u5f20\u7684\u6574\u4f53\u529f\u80fd[1],\u5fc3\u5ba4\u5c04\u8840\u5206\u6570(EF)\u53cd\u6620\u7684\u4ec5\u4ec5\u662f\u5fc3\u5ba4\u7684\u6536\u7f29\u529f\u80fd,\u4ee5\u5f80\u62a5\u9053\u5e94\u7528Tei\u6307\u6570\u8bc4\u4ef7\u51a0\u5fc3\u75c5\u60a3\u8005\u53f3\u5fc3\u529f\u80fd[2]\u3002\u672c\u7814\u7a76\u7ed3\u679c\u663e\u793a\u5fc3\u810f\u79fb\u690d\u7ec4\u5176\u5de6\u5ba4\u5c04\u8840\u5206\u6570\u53ca\u5de6\u5ba4Tei\u6307\u6570\u4e0e\u6b63\u5e38\u5bf9\u7167\u7ec4\u6bd4\u8f83,\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49(P>0.05),\u4f46\u5fc3\u810f\u79fb\u690d\u7ec4\u53f3\u5ba4\u7684Tei\u6307\u6570\u8f83\u6b63\u5e38\u7ec4\u9ad8(P<0.05),\u8868\u660e\u5fc3\u810f\u79fb\u690d\u672f\u540e,\u53f3\u5ba4\u7684\u6574\u4f53\u529f\u80fd\u8f83\u5de6\u5ba4\u66f4\u65e9\u51cf\u9000,\u8fd9\u53ef\u80fd\u4e0e\u5fc3\u810f\u79fb\u690d\u672f\u524d\u7ee7\u53d1\u6027\u80ba\u52a8\u8109\u9ad8\u538b\u6709\u5173\u3002\u00b71222\u00b7\u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7(\u7535\u5b50\u7248)2008\u5e7411\u6708\u7b2c2\u5377\u7b2c11\u671fChinJClinicians(ElectronicVersion),November15,2008,Vol.2,No.11\ufffd\u4f20\u7edf\u8bc4\u4ef7\u5de6\u5fc3\u5ba4\u8212\u5f20\u529f\u80fd\u7684\u65b9\u6cd5\u662f\u6839\u636e\u4e8c\u5c16\u74e3\u53e3\u8840\u6d41\u9891\u8c31\u4f5c\u51fa\u8bc4\u5224,\u800c\u4e14\u5bf9\u8f7b\u5ea6\u8212\u5f20\u529f\u80fd\u53d7\u635f\u65f6\u5f88\u654f\u611f,\u4f46\u5f53\u8212\u5f20\u529f\u80fd\u4e2d\u5ea6\u53d7\u635f\u65f6\u5bb9\u6613\u51fa\u73b0\u5047\u8c61,\u800c\u4e14\u53d7\u8d1f\u8377\u7b49\u591a\u79cd\u56e0\u7d20\u7684\u5f71\u54cd\u3002\u8fd1\u5e74\u6765,\u591a\u666e\u52d2\u7ec4\u7ec7\u6210\u50cf(DTI)\u6280\u672f\u95ee\u4e16\u540e,\u53ef\u4ee5\u901a\u8fc7\u6d4b\u5b9a\u4e8c\u5c16\u74e3\u73af\u4f4d\u7f6e\u7684\u5fc3\u808c\u8fd0\u52a8\u901f\u5ea6,\u8bc4\u4ef7\u5de6\u5ba4\u6536\u7f29\u53ca\u8212\u5f20\u529f\u80fd,\u5c24\u5176QTVI\u6280\u672f\u80fd\u540c\u65f6\u6bd4\u8f83\u5fc3\u808c\u591a\u8282\u6bb5\u8fd0\u52a8,\u53ef\u4ee5\u83b7\u5f97\u51c6\u786e\u7684\u5c40\u57df\u5fc3\u808c\u8fd0\u52a8\u66f2\u7ebf,\u8fdb\u884c\u5b9a\u91cf\u5206\u6790,\u4e3a\u8bc4\u4ef7\u5fc3\u810f\u8282\u6bb5\u6536\u7f29\u53ca\u8212\u5f20\u529f\u80fd\u63d0\u4f9b\u4e86\u65b0\u65b9\u6cd5[3-7]\u3002\u672c\u7814\u7a76\u5e94\u7528\u4e8c\u5c16\u74e3\u3001\u4e09\u5c16\u74e3\u8840\u6d41\u56fe\u8bc4\u4ef7\u5de6\u53f3\u5ba4\u8212\u5f20\u529f\u80fd,\u7ed3\u679c\u8868\u660e\u5fc3\u810f\u79fb\u690d\u7ec4\u4e8c\u5c16\u74e3\u53e3\u8840\u6d41\u56feE\u5cf0\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u8f83\u6b63\u5e38\u7ec4\u4f4e(P<0.05);\u5fc3\u810f\u79fb\u690d\u7ec4\u4e09\u5c16\u74e3\u53e3\u8840\u6d41\u56feA\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u6bd4\u6b63\u5e38\u7ec4\u9ad8,E/A\u6bd4\u503c\u8f83\u6b63\u5e38\u7ec4\u4f4e(P<0.05),\u4f46\u65e0\u8bba\u662f\u6b63\u5e38\u5bf9\u7167\u7ec4\u6216\u5fc3\u810f\u79fb\u690d\u7ec4E/A\u6bd4\u503c\u5747\u5927\u4e8e1,\u7531\u6b64\u53ef\u89c1\u5fc3\u810f\u79fb\u690d\u7ec4\u5de6\u53f3\u5ba4\u8212\u5f20\u529f\u80fd\u672a\u89c1\u5f02\u5e38\u3002\u672c\u7814\u7a76\u5e94\u7528\u4e8c\u5c16\u74e3\u74e3\u73af\u901f\u5ea6\u56fe\u3001\u4e09\u5c16\u74e3\u74e3\u73af\u901f\u5ea6\u56fe\u3001\u5fc3\u5c16\u56db\u8154\u5fc3\u5207\u9762\u5ba4\u95f4\u9694\u901f\u5ea6\u56fe\u3001\u5de6\u5ba4\u4fa7\u58c1\u901f\u5ea6\u56fe\u3001\u53f3\u5ba4\u4fa7\u58c1\u901f\u5ea6\u56fe\u8bc4\u4ef7\u5de6\u53f3\u5ba4\u6536\u7f29\u53ca\u8212\u5f20\u529f\u80fd,\u7ed3\u679c\u8868\u660e\u5ba4\u95f4\u9694E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u5fc3\u810f\u79fb\u690d\u7ec4\u8f83\u6b63\u5e38\u4f4e(P<0.01),\u4e09\u5c16\u74e3\u74e3\u73af\u53f3\u5ba4\u4fa7\u58c1\u7684\u6536\u7f29\u901f\u5ea6\u3001E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u5747\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e(P<0.01,P<0.05,P<0.05),\u800cE/A\u6bd4\u503c\u8f83\u6b63\u5e38\u7ec4\u9ad8(P<0.05);\u53f3\u5ba4\u4fa7\u58c1\u7684\u6536\u7f29\u901f\u5ea6\u3001E\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u3001A\u5cf0\u7684\u5cf0\u503c\u901f\u5ea6\u5747\u8f83\u6b63\u5e38\u5bf9\u7167\u7ec4\u4f4e(P\u5747<0.05),E/A\u6bd4\u503c\u8f83\u6b63\u5e38\u7ec4\u9ad8(P<0.05)\u3002\u7efc\u4e0a\u6240\u8ff0,\u5fc3\u810f\u79fb\u690d\u7ec4\u5176\u53f3\u5ba4\u6536\u7f29\u529f\u80fd\u51cf\u9000,\u800c\u5de6\u53f3\u5fc3\u5ba4\u8212\u5f20\u529f\u80fd\u672a\u89c1\u5f02\u5e38,\u4e0e\u4ee5\u5f80\u62a5\u9053\u4e00\u81f4[8],\u53ef\u80fd\u4e0e\u5fc3\u810f\u79fb\u690d\u60a3\u8005\u79fb\u690d\u672f\u524d\u7ee7\u53d1\u6027\u80ba\u52a8\u8109\u9ad8\u538b\u6709\u5173\u3002\u53c2\u8003\u6587\u732e[1]TeiC,LingLH,HodgeDO,etal.Newindexofcombinedsystolicanddiastolicmyocardialperformance:asimpleandreproduciblemeasureofcardiacfunction-astudyinnormalsanddilatedcardiomyopathy.JCardiol,1995,26(6):357-366.[2]\u7a0b\u857e\u857e,\u8212\u5148\u7ea2,\u674e\u4f1f\u971e,\u7b49.Tei\u6307\u6570\u8bc4\u4ef7\u51a0\u5fc3\u75c5\u60a3\u8005\u53f3\u5fc3\u529f\u80fd\u7684\u4e34\u5e8a\u7814\u7a76.\u4e2d\u56fd\u8d85\u58f0\u533b\u5b66\u6742\u5fd7,2005,21(11):827-829.[3]\u5b59\u8f89,\u91d1\u4e3d\u5a1f,\u5d14\u6797,\u7b49.\u5b9a\u91cf\u7ec4\u7ec7\u901f\u5ea6\u6210\u50cf\u5bf9\u5fc3\u808c\u7f3a\u8840\u7684\u8bc4\u4ef7.\u4e2d\u56fd\u8d85\u58f0\u533b\u5b66\u6742\u5fd7,2002,19(4):280-282.[4]CardimN,OliveiraAG,LongoS,etal.Dopplertissueimaging:regionalmyocardialfunctioninhypertrophiccardiomyopathyandinathlete\u2032sheart.JAmSocEchocardiogr,2003,16(3):223-232.[5]StengelSM,AllemannY,ZimmerliM,etal.Dopplertissueimagingforassessingleftventriculardiastolicdysfunctioninhearttransplantrejection.Heart,2001,86(4):432-437.[6]FyfeDA,KetchumD,LewisR,etal.TissueDopplerimagingdetectsseverelyabnormalmyocardialvelocitiesthatidentifychildrenwithpre-terminalcardiacgraftfailureafterhearttransplantation.JHeartLungTransplant,2006,25(5):510-517.[7]\u7a0b\u857e\u857e,\u8212\u5148\u7ea2,\u8c2d\u5fb7\u82f1,\u7b49.\u591a\u666e\u52d2\u7ec4\u7ec7\u6210\u50cf\u8bc4\u4ef7\u51a0\u5fc3\u75c5\u60a3\u8005\u53f3\u5ba4\u58c1\u8fd0\u52a8\u7684\u521d\u6b65\u7814\u7a76.\u4e2d\u56fd\u8d85\u58f0\u533b\u5b66\u6742\u5fd7,2002,18(9):662-665.[8]FyfeDA,MahleWT,KanterKR,etal.Reductionoftricuspidannulardopplertissuevelocitiesinpediatrichearttransplantpatients.JHeartLungTransplant,2003,22(5):553-559.(\u6536\u7a3f\u65e5\u671f:2008-07-09)(\u672c\u6587\u7f16\u8f91:\u5434\u83b9)\u672c\u6587\u6587\u732e\u6807\u5f15\u683c\u5f0f:\u6f58\u7fe0\u73cd,\u6768\u58f0\u663e,\u8212\u5148\u7ea2,\u7b49.\u5fc3\u810f\u79fb\u690d\u672f\u540e\u5de6\u53f3\u5fc3\u5ba4\u529f\u80fd\u53d8\u5316\u7684\u4e34\u5e8a\u4ef7\u503c[J/CD].\u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7(\u7535\u5b50\u7248),2008,2(11):1218-1223.\u00b71223\u00b7\u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7(\u7535\u5b50\u7248)2008\u5e7411\u6708\u7b2c2\u5377\u7b2c11\u671fChinJClinicians(ElectronicVersion),November15,2008,Vol.2,No.11\ufffd\n\n"}